This is an updated version of a survey first published in April 2001, covering offers by pharmaceutical companies and generic manufacturers of discounted prices for antiretroviral drugs.
To print this table, we recommend that you select `Landscape` mode by going to Print in your browser and then select `Preferences` in Internet Explorer or `Properties` in Netscape, and adjust the print mode to `Landscape` in the Orientation section.
style='width:100.0%;margin-left:-5.65pt;border-collapse:collapse;border:none;
mso-border-alt:solid windowtext .75pt;mso-padding-alt:5.25pt 5.25pt 5.25pt 5.25pt'>
Generic name
Brand Name
Initials
Manufacturer
Discount Price (on standard dose unless
stated)
Special provisions
Generic Alternative (Country/manufacturer name)
style='font-family:Verdana'>
Protease inhibitors
Lopinavir
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>/ritonavir
Kaletra
N/a
Abbott
c.$650per year
Further cuts promised
Africa
(available to private sector or company health plans and
NGOs, as well as govts)
None
Ritonavir
Norvir
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
N/a
Abbott
c. $650
Further cuts promised
Africa
(available to private sector or company health plans and
NGOs, as well as govts)
India (Hetero - c. $4300 p.a.)
Nelfinavir
Viracept
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
N/a
Roche
$1800 p.a
Sub-Saharan Africa
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
(Hetero - $2248 p.a.)
Saquinavir
Fortovase
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
N/a
Roche
c. $670 for SQV when dosed at 1800mg qd
with ritonavir 100mg
c.$800 when dosed at 100mg/100mg twice daily
Sub-Saharan Africa
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
(Hetero - $992 p.a.)
Indinavir
Crixivan
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
N/a
Merck
$600 per year
Africa
Romania
Haiti
Brazil
(Available to NGOs and company health plans, as well as govts)
India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>:
CIPLA - $2300 p.a at 800mg tid)
Ranbaxy: Virodin
Hetero – Indivir
($1840 p.a. at 800mg tid)
Non-nucleoside reverse transcriptase
inhibitors (NNRTIs)
Nevirapine
Viramune
Boehringer Ingelheim
Free as two doses for mother and infant treatment
$1.22 per day for adult dosing ($445 p.a)
Maternal/infant treatment free to all non-EU countries
(also excludes
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>USA
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>,
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>Canada
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>, NZ,
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>Australia
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>,
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>Japan
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>,
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>Switzerland
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>,
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>Norway
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>,
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>Iceland
style='font-size:9.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>)
Nevirapine has been patented in 25 African countries
India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>:
class=SpellE>Cipla
(Nevimune $197p.a. to non-profits)
Ranbaxy: Nevipan
Hetero: Nevivir
Efavirenz
Stocrin
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
N/a
Merck
$500 per year
Africa Romania
Haiti
Brazil ($846 pa)
(Available to NGOs and company health plans, as well as
govts)
India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
(Aurobindo $485 p.a)
Nucleoside analogues (NRTIs)
Stavudine
Zerit
D4T
Bristol
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'> Myers
Squibb
15 cents a day/$54 per year
for dose applicable to adults 60kg and over; lower cost
applies at lower body weight
Not available to private sector/company health plans
Note: Stavudine is not patented in any African country
except South Africa
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>:
class=SpellE>Cipla
(Stavir;$40 p.a to non-profits)
Ranbaxy: Virostav
Hetero/Genix Pharma:
style='mso-bidi-font-style:normal'>Stag
Thailand
Brazil
Didanosine
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
Videx
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
DdI
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
Bristol
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'> Myers
Squibb
80 cents per day/ $310 p.a. for dose applicable to
adults 60kg and over; lower cost applies at lower body weight
Not available to private sector/company health plans
Note: Didanosine is not
patented in any African country except
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>South
Africa
Thailand: non-buffered version Brazil
India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
(CIPLA - $584; Aurobindo $190 p.a)
Zidovudine and lamivudine
Combivir
AZT and 3TC
Glaxo Smith Kline
$2 per day
($730 p.a)
Developing countries - govts, NGOs and workplace
initiatives where suitable medical infrastructure exists, via UNAIDS
Accelerating Access Initiative
India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
(CIPLA - Duovir $554 pa to
non-profits
Ranbaxy
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'> –
class=SpellE>Virocomb
style='mso-spacerun:yes'>
($346 pa)
Zidovudine
Retrovir
AZT
Glaxo Smith Kline
95% reduction on "average global price"
As above
India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
(CIPLA: Zidovir $306 p.a
lang=NL style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana;
mso-ansi-language:NL'>
Ranbaxy:
style='mso-bidi-font-style:normal'>Viro-2
Hetero: Zido-H
Abacavir
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
Ziagen
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
N/a
Glaxo Smith Kline
As above
Lamivudine
Epivir
3TC
Glaxo Smith Kline
58 cents per day
As above
Note: Lamivudine is patented in 33 African countries
CIPLA -
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
(Lamivir,
30 cents per day to non-profits)
Hetero/GenixPharma:
style='mso-bidi-font-style:normal'>Heptavir
(marketed for hepatitis B treatment)
Ranbaxy: Virolam
Zalcitabine
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
Hivid
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
ddC
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
Roche
Available at cost
Brazil
Combinations
of generics
Lamivudine, zidovudine and nevirapine
AZT, 3TC and nevirapine
CIPLA
$350 p.a
Non-profits
(Govts $600 p.a)
Note: each component of this combination is
patented in 23 African countries
Aurobindo
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'> (
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>India
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>)
$295 p.a
Offered to govt health progs
Lamivudine, stavudine and nevirapine
3TC, d4T and nevirapine
Hetero (India)
$350 p.a
Offered to govt health progs
Note :
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
stavudine dose within these formulations is 40mg bid – lower doses for lower
body weight have not been announced.
Ranbaxy
lang=FR style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana;
mso-ansi-language:FR'> (India) –
style='mso-bidi-font-style:normal'>Virolans 30
style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana'>
$388 (295 p.a to MSF and NGOs)
General Pharmaceutical Organization (Thailand)
lang=FR style='font-size:10.0pt;mso-bidi-font-size:12.0pt;font-family:Verdana;
mso-ansi-language:FR'>
$324 p.a